Saponins from the Spanish saffron Crocus sativus are efficient adjuvants for protein-based vaccines

Vaccine

Volumn 30, Issue 2, 2012, Pages 388-397

  Castro Díaz, Nathaly ^a   Salaun, Bruno ^b   Perret, Rachel ^b   Sierro, Sophie ^b   Romero, Jackeline F ^b   Fernández, Jose Antonio ^a   Rubio Moraga, Angela ^a   Romero, Pedro ^b  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Adjuvant; Crocus sativus; Saponins; T Lymphocytes

Indexed keywords

ADJUVANT; CS 5; OVALBUMIN; PROTEIN VACCINE; SAPONIN; SAPONIN DERIVATIVE; TUMOR ANTIGEN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROCUS SATIVUS; DRUG EFFICACY; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IN VIVO STUDY; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR; TUMOR XENOGRAFT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CANCER VACCINES; CROCUS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS; SAPONINS; VACCINES, SUBUNIT;

EID: 84355162745     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.080     Document Type: Article

References (28)

1. Petrovsky N., Aguilar J.C. Vaccine adjuvants: current state and future trends. Immunol Cell Biol 2004, 82(5):488-496.
2. Leroux-Roels G. Unmet needs in modern vaccinology adjuvants to improve the immune response. Vaccine 2010, 28(SUPPL. 3):C25-C36.
3. Gupta R.K. Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev 1998, 32(3):155-172.
4. Lindblad E.B. Aluminium adjuvants-in retrospect and prospect. Vaccine 2004, 22(27-28):3658-3668.
5. Speiser D.E., Lienard D., Rufer N., Rubio-Godoy V., Rimoldi D., Lejeune F., et al. Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J Clin Invest 2005, 115(3):739-746.
6. Kensil C.R. Saponins as vaccine adjuvants. Crit Rev Ther Drug Carrier Syst 1996, 13(1-2):1-55.
7. Kirk D.D., Rempel R., Pinkhasov J., Walmsley A.M. Application of Quillaja saponaria extracts as oral adjuvants for plant-made vaccines. Expert Opin Biol Ther 2004, 4(6):947-958.
8. Meraldi V., Romero J.F., Kensil C., Corradin G. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites. Vaccine 2005, 23(21):2801-2812.
9. Soltysik S., Wu J.Y., Recchia J., Wheeler D.A., Newman M.J., Coughlin R.T., et al. Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Vaccine 1995, 13(15):1403-1410.
10. Takahashi H., Takeshita T., Morein B., Putney S., Germain R.N., Berzofsky J.A. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 1990, 344(6269):873-875.
11. Gupta R.K., Relyveld E.H., Lindblad E.B., Bizzini B., Ben-Efraim S., Gupta C.K. Adjuvants-a balance between toxicity and adjuvanticity. Vaccine 1993, 11(3):293-306.
12. Duewell P., Kisser U., Heckelsmiller K., Hoves S., Stoitzner P., Koernig S., et al. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells. J Immunol 2011, 187(July (1)):55-63.
13. Song X., Hu S. Adjuvant activities of saponins from traditional Chinese medicinal herbs. Vaccine 2009, 27(36):4883-4890. [epub 2009 Jun 24].
14. Abdullaev F.I., Espinosa-Aguirre J.J. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev 2004, 28(6):426-432.
15. Rubio-Moraga A.G., Gerrit J., Castro-Dióaz N., Jimeno M.L., Escribano J., Fernaóndez J.-A., et al. Triterpenoid saponins from corms of Crocus sativus: localization, extraction and characterization. Ind Crops Prod 2011, 34(3):1401-1409.
16. Matthews V.B., Morahan G., Price P. A locus affecting immunoglobulin isotype selection (Igis1) maps to the MHC region in C57BL, BALB/c and NOD mice. Immunol Cell Biol 2001, 79(December (6)):576-582.
17. Karanam B., Gambhira R., Peng S., Jagu S., Kim D.J., Ketner G.W., et al. Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity. Vaccine 2009, 27(7):1040-1049.
18. Sun H.X., Xie Y., Ye Y.P. Advances in saponin-based adjuvants. Vaccine 2009, 27(12):1787-1796.
19. Miconnet I., Koenig S., Speiser D., Krieg A., Guillaume P., Cerottini J.C., et al. CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide. J Immunol 2002, 168(3):1212-1218.
20. Liu G., Anderson C., Scaltreto H., Barbon J., Kensil C.R. QS-21 structure/function studies: effect of acylation on adjuvant activity. Vaccine 2002, 20(21-22):2808-2815.
21. Marciani D.J., Reynolds R.C., Pathak A.K., Finley-Woodman K., May R.D. Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100. Vaccine 2003, 21(25-26):3961-3971.
22. Sun Y., Tong H., Li M., Li Y., Guan S., Liu J. Immunological adjuvant effect of Japanese ginseng saponins (JGS) on specific antibody and cellular response to ovalbumin and its haemolytic activities. Vaccine 2008, 26(47):5911-5917.
23. Bangham A.D., Horne R.W., Glauert A.M., Dingle J.T., Lucy J.A. Action of saponin on biological cell membranes. Nature 1962, 196:952-955.
24. Singh M., O'Hagan D. Advances in vaccine adjuvants. Nat Biotechnol 1999, 17(11):1075-1081.
25. Xie Y., Ye Y.P., Sun H.X., Li D. Contribution of the glycidic moieties to the haemolytic and adjuvant activity of platycodigenin-type saponins from the root of Platycodon grandiflorum. Vaccine 2008, 26(27-28):3452-3460.
26. Marciani D.J., Pathak A.K., Reynolds R.C., Seitz L., May R.D. Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins. Int Immunopharmacol 2001, 1(4):813-818.
27. Marciani D.J. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov Today 2003, 8(October (20)):934-943.
28. Kensil C.R., Patel U., Lennick M., Marciani D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J Immunol 1991, 146(January (2)):431-437.